Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Correvio Pharma Corp. CORV

Healthcare Drug Manufacturers - Major
Correvio Pharma Corp is specialty pharmaceutical company. It offers patients and healthcare providers therapeutic solutions for acute medical conditions to improve health and quality of life. Its products are Aggrastat, Esmocard, Brinavess, Xydalba, Zevtera/Mabelio, and others. It offers solutions on Acute Bacterial Skin and Skin Structure Infections, Acute Coronary Syndromes, Atrial... see more

Recent & Breaking News (NDAQ:CORV)

Correvio Obtains Final Order for Plan of Arrangement

Canada NewsWire May 21, 2020

Correvio Announces Results from Annual General and Special Meeting of Securityholders

Canada NewsWire May 15, 2020

Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA

Canada NewsWire May 6, 2020

Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19

Canada NewsWire May 4, 2020

Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA

Canada NewsWire May 1, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?

PR Newswire April 20, 2020

Correvio Obtains Interim Order For Plan Of Arrangement

Canada NewsWire April 8, 2020

Correvio Reports Full Year 2019 Financial Results

PR Newswire March 30, 2020

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - CORV, TERP, IOTS, CBB

GlobeNewswire March 24, 2020

CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV

Business Wire March 20, 2020

Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - TTPH, CORV

ACCESSWIRE IA March 16, 2020

ADVANZ PHARMA to Acquire Correvio

Canada NewsWire March 16, 2020

Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China

Canada NewsWire March 10, 2020

Correvio Responds to Market Activity

Canada NewsWire March 2, 2020

FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 10, 2020

INVESTOR ALERT - Correvio Pharma Corp. (CORV) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 10, 2020

GlobeNewswire February 10, 2020

FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 7, 2020

CORREVIO INVESTOR DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Correvio Pharma Corp. To Contact The Firm

Business Wire February 7, 2020

FINAL DEADLINE FEBRUARY 10: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 6, 2020

SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Correvio Pharma Corporation of Class Action Lawsuit and Upcoming Deadline - CORV

GlobeNewswire February 6, 2020